[Secukinumab (plaque psoriasis in children and adolescents) - Addendum to Commission A20-78]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003802
German
Original Title: Secukinumab (Plaque-Psoriasis bei Kindern und Jugendlichen) - Addendum zum Auftrag A20-78
Details
Project Status: Completed
Year Published: 2021
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Psoriasis
  • Antibodies, Monoclonal, Humanized
  • Child
  • Adolescent
  • Dermatologic Agents
Keywords
  • Secukinumab
  • Psoriasis
  • Child
  • Adolescent
  • Benefit Assessment
  • NCT02471144
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.